Home Life Sciences PI3K/AKT/mTOR pathway and its related molecules participate in PROK1 silence-induced anti-tumor effects on pancreatic cancer
Article Open Access

PI3K/AKT/mTOR pathway and its related molecules participate in PROK1 silence-induced anti-tumor effects on pancreatic cancer

  • Feng Wang , Xiaogang Yan , Yongqiang Hua , Jianjun Song , Di Liu , Chun Yang , Fei Peng , Fuping Kang and Yongfeng Hui EMAIL logo
Published/Copyright: April 10, 2023

Abstract

The PI3K/AKT/mTOR (phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin) pathway can be initiated by PROK1 (prokineticin 1), but its effect and mechanism of action in pancreatic carcinoma (PC) are not fully understood. In this study, we elucidated the roles of PROK1 and its related molecules in PC in vivo. PANC-1 cells with PROK1 knockdown were injected into BALB/c nude mice. The growth and weight of the tumor were monitored and measured, which was followed by TUNEL (terminal deoxynucleotidyl transferase biotin-dUTP nick end labeling), immunohistochemical staining, and hematoxylin and eosin staining. The key proteins related to proliferation, apoptosis, and the PI3K/AKT/mTOR pathway were determined by Western blotting. We also used public databases to identify the molecules related to PROK1. The reduction of PROK1 inhibited angiopoiesis and promoted apoptosis in vivo. PCNA-1, cyclin D1, and Bcl-2 decreased considerably, while Bax and cleaved caspase-3 increased significantly after PROK1 inhibition. The PI3K/AKT/mTOR signal inhibition was also closely associated with PROK1 knockdown. The possible related molecules of PROK1, such as von Willebrand factor, were screened and considered to be involved in the aberrant activation of PI3K/AKT. In conclusion, PROK1 knockdown significantly prevented tumor growth and promoted apoptosis of human PC cells in vivo, where the PI3K/AKT/mTOR pathway was probably inhibited. Therefore, PROK1, along with its related molecules, might be important targets for PC therapy.

1 Introduction

Pancreatic carcinoma (PC) occurs in the digestive system. It has a high degree of malignancy and leads to more than 460,000 deaths worldwide in 2020 [1]. PC ranks fourth in the United States and other developed countries for cancer-related mortality. The PC mortality rate in China is 2.62/100,000 and ranks tenth for malignant tumor-related death [2]. The incidence of PC is increasing every year worldwide. Although surgery is commonly performed for treating PC, it is not specific to the early stage of the disease. The cancer cells can infiltrate and metastasize at an early stage of cancer; less than 20% of the patients with PC can be treated by surgical resection [3]. PC has an extremely poor prognosis, even in those who undergo surgery, and the incidence of complications even after an operation and local or regional recurrence remains high. The average survival time of PC patients is less than 6 months, the 5-year survival rate is < 5%, and 90% of the patients who do not undergo surgery die within 1 year [4].

Angiogenesis induced by cancer, including PC, promotes tumor growth, invasion, and metastasis. Proangiogenic factors stimulate vascular endothelial cell proliferation and angiogenesis [5]. PROK1 (prokineticin 1), also known as EG-VEGF, is the first tissue-specific proangiogenic factor that was found to contract gastrointestinal smooth muscles and promote intestinal motility. High levels of PROK1 are found in steroid hormone-producing organs, such as the ovary, testes, adrenals, and placenta, and it participates in the development of tumors in various specific and related tissues [6]. PROK1 is diffusely distributed in PC tissues, with a positive expression rate of up to 95%, indicating that PROK1 and the occurrence and development of PC might be correlated [7,8].

The PI3K/AKT/mTOR (phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin) pathway is an important signaling pathway in cells and can be activated by PROK1. The pathway participates in cell growth, proliferation, apoptosis, and also various pathological processes of human cancer [9]. PI3K is an upstream signaling molecule of the PI3K/AKT/mTOR pathway and is a key member of the phospholipase kinase family with lipid and protein kinase activity [10]. PI3Ks are mainly of three types, but only PI3K1 is closely related to tumorigenesis [11]. AKT is an important downstream kinase in the PI3K/AKT/mTOR signaling pathway, and it can be converted to phosphorylated AKT by the PI3K-mediated activation of the growth factor receptor. The phosphorylated AKT (p-AKT) can activate multiple downstream signaling molecules [12], inhibit tumor cell autophagy through mTOR, phosphorylate MADD, caspase-3, caspase-9, phosphorylate FOXO-1 to control the cell cycle, and promote tumor cell growth and/or metastasis [13,14]. mTOR is one of the main downstream signaling molecules and regulates cyclin D1, Bad, and Bcl-2. To summarize, the PI3K/AKT/mTOR pathway promotes tumor cell proliferation, migration, and angiogenesis [15]. The PI3K/AKT/mTOR pathway is continuously activated in most PC cell lines [16,17].

In this study, we transfected a specific lentivirus-mediated short hairpin RNA (shRNA) into pancreatic cells and studied the effect of PROK1 silencing on PC in vivo by monitoring the growth of the tumor, determining cell apoptosis, detecting the protein level of proliferation markers and anti-apoptotic markers, and measuring the activation level of the key molecules of the PI3K/AKT/mTOR signal.

2 Methods

2.1 Animals

Male BALB/c nude mice (Inbred strain of mouse, 6 weeks old) were obtained from Shanghai SLAC Laboratory Animal Co. Ltd. (China). The mice were kept under specific-pathogen-free conditions and provided with enough food, water, and space.

  1. Ethical approval: The research related to animal use has been complied with all the relevant national regulations and institutional policies for the care and use of animals, and was approved by the Ethics Committee of the General Hospital of Ningxia Medical University (approval number: KYLL-2022-0628).

2.2 shRNA-mediated knockdown of PROK1

The steps for the shRNA-mediated knockdown of PROK1 were the same as those followed in our previous study [8]. ShPROK1 was used to transfect PANC-1 cells to knock down PROK1 expression. The shRNA sequences for shPROK1 and the negative control (shCon) were designed and synthesized for the vector pYr-1.1-hU6-EGFP-Neo (Catalog No. #VRY0359, YRbio; Changsha, China). The shPROK1 sequence is as follows: 5′-CACCCTCCATGGACTTGAAGAACATCTCGAGATGTTCTTCAAGTCCATGGAGTTTTTTG-3′ (underlined: sequence target at PROK1). The negative control sequence is as follows: 5′-CACCCCTAAGGTTAAGTCGCCCTCGCTCGAGCGAGGGCGACTTAACCTTAGGTTTTTTG-3′ (underlined: sequence target at no gene). Before lentivirus packaging, the BsaI restriction enzyme (Dalian TAKARA Co. Ltd., China) was used to digest the shuttle plasmid, and then, T4 ligase was used to connect the pYr-1.1 fragments and anneal the double-stranded shRNA. The recombined lentivirus was used to infect the cells when cell confluence reached 80–90%. After 72 h, the supernatant was collected, centrifuged at 4°C, filtered with a filter (0.45 µm), and finally, the product was collected. Then, the cells were transferred to six-well plates and incubated at 37°C with 5% CO2 for 24 h. In the presence of polybrene (6 µg/mL), the cells were incubated with shPROK1. A scramble sequence, designated as shCon, was ligated into the vector and served as a negative control. After 24 h, the infected cells were screened out using puromycin, and the cells were harvested to assess the knockdown of PROK1.

2.3 Establishing a nude mouse xenograft model bearing human PC cells

Male BALB/c nude mice (6 weeks old; n = 10) were randomly divided into two groups. The mice in one group were injected with 2 × 106 control PANC-1 cells (shCon), and those in the other group were injected with PANC-1 cells transfected with sh-PROK1–1. The cell suspension (2 × 106 cells/mL, 200 µL) containing shPROK1 in PBS was injected into the right armpits, and the PC tumors were allowed to grow in the mice for 49 days. The tumor volume was measured using calipers, and the weight of all animals was recorded throughout the experiment. The tumor volume was calculated using the formula: tumor volume = length (cm) × width (cm2) × 0.5236. On Day 49, the mice were euthanized. The tumor tissue was macroscopically observed after execution and prepared for histopathology and biochemical analysis.

2.4 Immunohistochemical (IHC) staining

Subcutaneous PC tumor masses were used for the IHC analysis to detect the expression of PROK1 in human PC xenograft in BALB/c nude mice. The prepared sections (4 µm) were dry-roasted and dehydrated in an oven at 65°C for 30 min and then were dewaxed in xylene, dehydrated in alcohol, and finally immersed in a solution tank containing double distilled water for 10 min. The sections were immersed in 3% H2O2 for 10 min, washed in distilled water thrice for 2 min, and immersed in 0.01 M tannic acid repair solution. Finally, they were heated in a microwave oven for 10 min at 92–98°C. The sections were placed in a glass jar containing 3% hydrogen peroxide and incubated at room temperature for 15 min to eliminate endogenous peroxidase activity. Normal sheep serum blocking solution was added dropwise to the sections, which were then incubated at 37°C for 30 min. Then, the excess liquid was removed from the sections. The primary antibody against PROK1 (Santa Cruz Biotechnology; sc-30343; dilution, 1:50) or PCNA (Cell Signaling Technology; #13110; dilution, 1:10,000) was added to the sections, which were then placed in a humidified space at 4°C overnight. The sections were taken out of the refrigerator, rewarmed at 37°C for 30 min, and washed thrice with PBS buffer for 5 min. The biotin-labeled secondary antibody was then added dropwise to the sections and incubated at 37°C for 30 min. The sections were stained using the Histostain-Plus Generation 3 IHC Assay Kit (Invitrogen, USA) following the manufacturer’s protocol. The positively stained cells were counted (for PCNA) or densitometrically analyzed (for PROK1) in five views under a microscope.

2.5 TUNEL (terminal deoxynucleotidyl transferase-mediated nick end labeling)

The paraffin sections to be dyed were baked in an oven at 60°C for 3 h, dewaxed with xylene, and rehydrated using gradient alcohol. After adding proteinase K, the sections were incubated at 37°C for 8 min, followed by the addition of 0.3% hydrogen peroxide in methanol and incubation for 10 min at room temperature to block endogenous peroxide enzymes. Then, 0.1% (v/v) Triton–sodium citrate was added to the sections for 10 min for cell penetration and antigen retrieval. The TUNEL reaction mixture solution was added and incubated at 37°C in a dark box for 1.5 h. Next, the transformant-POD was added and incubated in the wet box for 30 min at 37°C. After the DAB substrate solution was added, the samples were incubated at room temperature for 1–2 min. The sections were counterstained with hematoxylin for 30 s and differentiated with 1% hydrochloric acid alcohol for 5 s. Then, the sections were dehydrated with alcohol, treated with xylene, covered with a coverslip, and sealed with neutral gum. Finally, the sections were analyzed under a confocal laser scanning microscope.

2.6 Western blot analysis

The tumor tissue collected from the nude mice was ground to a granular shape with liquid nitrogen in a mortar. The tissue was placed in a 1.5 mL centrifuge tube. To 100–200 µL of the cell lysate, a pre-warmed 1× SDS gel-loading buffer was added as soon as possible. The sample was placed in a boiling water bath for 5 min. Then, the sample was centrifuged at 10,000 rpm at room temperature. The BCA Protein Assay Reagent (Millipore, Bedford; MA, USA) was used to quantify the extracted protein. The collected proteins (30 mg) were separated by 8% SDS-PAGE and transferred onto a PVDF membrane. After blocking the membrane with non-fat milk (5%) for 2 h, the primary antibodies against the following antigens were incubated with the membrane overnight at 4°C for 24 h: PROK1 (Santa Cruz Biotechnology; sc-30343; dilution, 1:300), PCNA (CST; #13110; dilution, 1:2,000), cyclin D1 (CST; #55506; dilution, 1:2,000), Bax (CST; #2772; dilution, 1:1,000), Bcl-2 (CST; #4223; dilution, 1:1,000), cleaved caspase-3 (CST; #9654; dilution, 1:1,000), PI3K (Abcam; ab154598; dilution, 1:2,000), phospho-PI3K [Tyr458] (Abcam; ab278545; dilution, 1:2,000), AKT (Abcam; ab8805; dilution, 1:500), phospho-AKT [Ser473] (Abcam; ab81283; dilution, 1:5,000), mTOR (Abcam; ab32028; dilution, 1:2,500), and phospho-mTOR [Ser2448] (Abcam; ab109268; dilution, 1:5,000). The samples were incubated with horseradish peroxidase-conjugated secondary antibodies at room temperature for 2 h. The signals were detected using an ECL system (Amersham Biosciences, USA). Densitometric analysis of the blots was performed using the ImageJ software.

2.7 Histological analysis

The samples were fixed with neutral formalin solution (10%) for 1 day and rinsed. Increasing concentrations of ethanol were used to dehydrate the samples. The tissues were embedded in paraffin and cut into 4 µm sections using a microtome. A graded descending ethanol series, including 100, 90, and 70% ethanol solutions (5 min each) and dH2O (10 min), were used to deparaffinize and rehydrate the sections successively. Finally, the sections were stained with hematoxylin and eosin (H&E) using the conventional method.

2.8 Public data mining

We further determined the related molecules that regulate PROK1 or are regulated or affected by PROK1 using GEPIA 2 (http://gepia2.cancer-pku.cn/) in the next-generation sequencing databases TCGA (https://portal.gdc.cancer.gov/) and GTEx (https://www.gtexportal.orghome/). The expression level of PROK1 and its possible related genes (von Willebrand factor [VWF], GNG11, FGF7, TNXB, IL3RA, and LPAR1) in PAAD (pancreatic adenocarcinoma) and the data from paired adjacent tissue or normal pancreas tissue served as the control. The association between the expression level of the genes and the survival of the patients was analyzed. Initially, the possible related genes were screened out (criteria: Pearson’s correlation coefficient >0.3 and top 500 genes) from those that were significantly correlated with PROK1 in the PAAD dataset from the TCGA database using the tools “Similar Genes Detection” on GEPIA 2 and then were assessed by the KEGG enrichment analysis (WebGestalt, http://www.webgestalt.org/). We selected the genes enriched in the PI3K/AKT signaling pathway and overlapped them with all differentially expressed genes (DEGs, cutoff: |Log2FC| = 1, p < 0.01) in PAAD. The protein levels of VWF, GNG11, FGF7, and IL3RA were obtained from THPA (https://www.proteinatlas.org/), and survival analysis was performed using the Kaplan–Meier plotter (https://kmplot.com/analysis/) or ToPP (http://www.biostatistics.online/topp/index.php) for univariate or multivariate factors.

2.9 Statistical analysis

Statistical analyses were performed using the GraphPad Prism software (version 8.0). All data are presented as mean ± SD (standard deviation) from at least three replicates. The differences among groups were determined by performing a one-way analysis of variance (ANOVA) followed by the least significant difference test. All differences among and between groups were considered to be statistically significant at P < 0.05.

3 Results

3.1 PROK1 knockdown decreased the volume and weight of human PC xenografts in BALB/c nude mice

Tumor volume was measured using calipers every 6 days, after 35 days post-injection. The differences in the tumor volume between the groups increased with time (P < 0.01, Figure 1a). The size of the tumor in the sh-PROK1–1 group was smaller than that in the shCon group (Figure 1b). Tumor weight was recorded after harvesting the tissue. The tumor weight of the sh-PROK1–1 group was lesser than that of the shCon group (P < 0.01, Figure 1c). These results indicated that PROK1 knockdown significantly inhibited the growth of PC in BALB/c nude mice. Because PROK1 is an angiogenic inducer, vascular characteristic changes could be determined from the results of H&E staining. After histological evaluation of the tissue, we found no other noticeable morphological changes in the blood vessels, but the formation of blood vessels decreased, and more fluid and crowded cells were present in the shPROK1 group than in the shCon group (Figure S1).

Figure 1 
                  PROK1 knockdown decreased the volume and weight of human PC xenograft in BALB/c nude mice. (a) Tumor volume was measured using calipers every week after injecting cancer cells. Ten mice in the shCon group were injected with 2 × 106 control PANC-1 cells, and the mice in the other group were injected with PANC-1 cells transfected with sh-PROK1–1. (b and c) We measured the size of tumor tissue using calipers and the tumor weight; *P < 0.05 and **P < 0.01, compared to the shCon group.
Figure 1

PROK1 knockdown decreased the volume and weight of human PC xenograft in BALB/c nude mice. (a) Tumor volume was measured using calipers every week after injecting cancer cells. Ten mice in the shCon group were injected with 2 × 106 control PANC-1 cells, and the mice in the other group were injected with PANC-1 cells transfected with sh-PROK1–1. (b and c) We measured the size of tumor tissue using calipers and the tumor weight; *P < 0.05 and **P < 0.01, compared to the shCon group.

3.2 PROK1 knockdown inhibited the PI3K/AKT/mTOR pathway and proliferation markers and increased apoptosis

The TUNEL micrographs of the tumor sliced from the sh-PROK1–1 group showed multiple brown-stained (TUNEL-positive, indicating apoptosis) cancer cells (Figure 2a). After PROK1 knockdown with shRNA, the proliferating marker PCNA-positive stained cells decreased significantly (Figure 2b). The results of the IHC analysis showed that PROK1 was weakly expressed in the shPROK1 group but strongly expressed in the shCon group (Figure 2c). This indicated that treatment with sh-PROK1–1 helped to maintain the reduced expression of PROK1 during tumor growth.

Figure 2 
                  PROK1 silencing increased apoptosis and decreased the expression of PROK1. (a) The TUNEL micrograph of the sh-PROK1–1 group. Multiple brown-stained cancer cells were found in the sh-PROK1–1-treated cells, indicating apoptosis. (b) The cell proliferation marker PCNA was detected by the IHC analysis. (c) The PROK1 protein level in PC tissues was detected by the IHC analysis. Scale bar: 100 µm; *P < 0.05 and **P < 0.01, versus the shCon group.
Figure 2

PROK1 silencing increased apoptosis and decreased the expression of PROK1. (a) The TUNEL micrograph of the sh-PROK1–1 group. Multiple brown-stained cancer cells were found in the sh-PROK1–1-treated cells, indicating apoptosis. (b) The cell proliferation marker PCNA was detected by the IHC analysis. (c) The PROK1 protein level in PC tissues was detected by the IHC analysis. Scale bar: 100 µm; *P < 0.05 and **P < 0.01, versus the shCon group.

The results of the Western blot analysis showed that the protein level of PCNA, cyclin D1, and Bcl-2 was lower in the shPROK1 group than that in the shCon group, while the protein level of Bax and cleaved caspase-3 in the shPROK1 group was higher than that in the other groups (Figure 3a and b). To determine whether the apoptosis of the human PC xenograft cells induced by PROK1 knockdown was related to the inactivation of the PI3K/AKT/mTOR signal, the level of the proteins associated with the pathway was measured. The results showed that the levels of p-PI3K, p-AKT, and p-mTOR were significantly reduced by the knockdown of PROK1 in the BALB/c mouse PC xenograft (P < 0.05 and P < 0.01 versus the shCon group), suggesting that the inhibition of the PI3K/AKT/mTOR pathway was induced by PROK1 knockdown (Figure 3c and d). To summarize, our results revealed that the inhibition of the phosphorylation of the PI3K/AKT/mTOR mediated by PROK1 knockdown induced cell apoptosis, which might be why PROK1 silencing promoted the human PC xenograft tissues to shrink and the cells in BALB/c nude mice to undergo apoptosis.

Figure 3 
                  Effect of PROK1 knockdown on proteins involved in the PI3K/AKT/mTOR pathway, proliferation, and apoptosis. (a and b) The protein levels of p-PI3K, PI3K, p-AKT, AKT, mTOR, and p-mTOR in the BALB/c mouse PC xenograft were measured by performing Western blotting, and densitometric analysis was performed using the ImageJ software. (c) Western blotting was performed to measure the relative expression of the PCNA and cyclin D1 proteins (markers expressed only in proliferating cells), Bcl-2 (a marker of anti-apoptosis), and Bax and cleaved caspase-3 (markers of pro-apoptosis). (d) The optical density of each protein was analyzed; *P < 0.05 and **P < 0.01, compared to the shCon group.
Figure 3

Effect of PROK1 knockdown on proteins involved in the PI3K/AKT/mTOR pathway, proliferation, and apoptosis. (a and b) The protein levels of p-PI3K, PI3K, p-AKT, AKT, mTOR, and p-mTOR in the BALB/c mouse PC xenograft were measured by performing Western blotting, and densitometric analysis was performed using the ImageJ software. (c) Western blotting was performed to measure the relative expression of the PCNA and cyclin D1 proteins (markers expressed only in proliferating cells), Bcl-2 (a marker of anti-apoptosis), and Bax and cleaved caspase-3 (markers of pro-apoptosis). (d) The optical density of each protein was analyzed; *P < 0.05 and **P < 0.01, compared to the shCon group.

3.3 The role of PROK1 in PC patient survival

The difference in the transcription of PROK1 in PAAD tissues and non-PAAD tissues was not significant (Figure 4a and b). Moreover, the expression level significantly increased with the increase in the tumor stage, suggesting a possible role in the progression of PAAD. The level of PROK1 and the overall survival (OS) or relapse-free survival (RFS) of PAAD patients were not associated (Figure 4c and d). Considering that the mutation of some genes like KRAS usually occurs in PAAD, we subgrouped the data with mutated or non-mutated KRAS and reanalyzed the relationship. In patients with mutated KRAS, higher PROK1 had longer RFS (Figure 4e). We also analyzed the relationship in stage 2 patients and found that survival probability (including OS and RFS) increased with the increase in the PROK1 level (Figure 4f and g), which was unexpected.

Figure 4 
                  The possible role of PROK1 in the survival of PAAD patients. (a and b) Using public sequencing data in the TCGA and GTEx databases and the online tools GEPIA 2, ToPP, and Kaplan–Meier plotter, the expression level of PROK1 in PAAD was determined. (c–g) The relationship between the expression level of PROK1 and the overall or progression-free survival of the patients was determined.
Figure 4

The possible role of PROK1 in the survival of PAAD patients. (a and b) Using public sequencing data in the TCGA and GTEx databases and the online tools GEPIA 2, ToPP, and Kaplan–Meier plotter, the expression level of PROK1 in PAAD was determined. (c–g) The relationship between the expression level of PROK1 and the overall or progression-free survival of the patients was determined.

3.4 The possible related molecules of PROK1 and their roles in regulating tumor growth in PC

The 500 genes correlated with PROK1 in PAAD (Pearson’s correlation, R > 0.3) were obtained from the TCGA database using GEPIA 2 and then submitted to WebGestalt for the KEGG pathway enrichment analysis. The results showed that they were mainly enriched in ovarian steroidogenesis, tryptophan metabolism, and malaria. However, several genes (including 11 genes: IGF1, NGFR, VWF, GNG11, NGF, FGF7, TNXB, IL3RA, LPAR1, TCL1B, and GH1) were associated with the activation of PI3K/AKT, which was interesting. These genes were overlapped with 9,170 DEGs in PAAD, which were obtained by comparing the mRNA expression profile between pancreatic cancer in TCGA and the normal pancreas in GTEx; six specific genes were found, including VWF, GNG11, FGF7, TNXB, IL3RA, and LPAR1 (Figure 5a and b). The expression of all six genes was significantly upregulated in PAAD compared to that in non-PAAD (Figure 5c). According to the data on THPA, most of these genes (VWF, GNG11, FGF7, and IL3RA) were also higher in PAAD tissues at the protein level (compared to non-tumor tissues, Figure 5d). The results of the univariate analysis for the association between the interested gene and the survival of the patients showed no notable relationship between them irrespective of whether KRAS was mutated (Figure S2). However, the results of the multivariate analysis showed that the increase in the transcription of these genes was associated with a decrease in the OS of the PAAD patients (Figure 5e).

Figure 5 
                  Screening of genes related to PROK1 and their expression and association with survival. (a) The correlated genes from GEPIA 2 were submitted to WebGestalt to perform gene enrichment. (b) The genes involved in PI3K/AKT signaling were overlapped with DEGs. After the intended genes were identified, their mRNA level, protein level, and possible association with survival were analyzed using (c) GEPIA 2, (d) THPA, and (e) ToPP.
Figure 5

Screening of genes related to PROK1 and their expression and association with survival. (a) The correlated genes from GEPIA 2 were submitted to WebGestalt to perform gene enrichment. (b) The genes involved in PI3K/AKT signaling were overlapped with DEGs. After the intended genes were identified, their mRNA level, protein level, and possible association with survival were analyzed using (c) GEPIA 2, (d) THPA, and (e) ToPP.

4 Discussion

Our results showed that PROK1 knockdown inhibited pancreatic tumor growth in vivo and reduced proliferating markers, such as PCNA and cyclin D1, at the molecular level. It also increased DNA damage and apoptosis markers (cleaved caspase-3 and Bax/Bcl-2 ratio) and inactivated PI3K/Akt/mTOR signaling. PROK1 binds to homologous G protein-coupled receptors, including PROKR1 and PROKR2. The PROK1/PROKR system has potent angiogenic activities in cancer development. In addition to promoting angiogenesis, PROK1 regulates cell migration and proliferation in normal and cancer cells [8,18,19]. PROKR1 expression is positively correlated with its ligand in trophoblasts that exhibit a “pseudo-tumorigenesis” feature [20,21], and PROKR1 mediates the proliferation of neuroblastoma cells [22]. Therefore, PROK1–PROKR1 interaction might be the key process by which PROK1 induces proliferation. In our study, the expression of PCNA and cyclin D1 proteins was considerably lower in the treated group than in the shCon group, suggesting that the downregulation of PROK1 inhibited the proliferation of human PC xenografts in nude mice. This provided additional evidence for the proliferative effects of PROK1 in cancer patients. The angiogenic and proliferative effects of PROK1 might contribute to poorer cancer-related survival in patients with pancreatic cancer and colorectal cancer [23].

Apoptosis, a type of classical programmed cell death, is an active, procedural, and intrinsic biological process characterized by a genetically controlled cell-autonomous death pattern. The unrestricted growth of tumors occurs due to the inhibition of tumor cell apoptosis. Thus, the apoptotic disorder is closely related to the occurrence, development, and malignant transformation of tumors [24]. Bcl-2 and Bax are closely related to apoptosis and belong to the Bcl-2 superfamily. These proteins have anti-apoptotic and pro-apoptotic effects, respectively [25]. When the Bax/Bcl-2 ratio increases, excess Bax proteins form homodimers and activate apoptosis, but when the ratio decreases, Bax-Bcl-2 heterodimer formation elicits a survival signal for both normal and tumor cells [26]. Caspase-3 belongs to the caspase family and is a very important protease that performs apoptosis, and it is activated at the end of the caspase cascade [27] through the successive cleavage of the interdomain linker and N-terminal prodomain. Its cleaved form is necessary for apoptotic chromatin condensation and DNA fragmentation [28,29]. To some extent, the level of expression of the caspase-3 gene determines how much caspase-3 can function [30]. We found in this study that the protein level of Bcl-2 decreased and that of Bax and cleaved caspase-3 increased, indicating that PROK1 silencing promoted the apoptotic death of tumor cells transplanted in nude mice. Our findings were similar to those of previous studies that showed PROK-1 induced Akt phosphorylation, upregulated the Bcl-2 family member Mcl-1, and acted as an anti-apoptotic effector in cancer cells [31,32].

Apoptosis is usually induced by intracellular pathways and/or signals outside cells [33]. The PI3K/AKT/mTOR pathway is important in cells and regulates various cellular activities, including proliferation and apoptosis [34]. However, its main function is to promote cell proliferation, survival, and the cell cycle and also participate in angiogenesis [35]. The PI3K/AKT/mTOR pathway can be activated by PROK1, which is associated with almost all human cancers [22,36]. Our experimental results and data mining results showed that PROK1 could also regulate the PI3K/AKT pathway, suggesting that the downregulation of PROK1 can inhibit PC cells, in which the PI3K/AKT/mTOR pathway probably participates.

Through data mining in the public databases, we found six genes, including VWF, GNG11, FGF7, TNXB, IL3RA, and LPAR1, which might be associated with the PI3K/AKT signaling pathway. Although the individual expression of these genes was not associated with patient survival, the combined tumor-promoting effect of these genes on PAAD needs further investigation as it might reveal their mechanism of action. Additionally, these genes were shown by other researchers to play important roles in cancer. For example, VWF inhibits bleeding, and its level is elevated in PC, which might be the reason for the development of thrombosis in these patients [37]. An increase in VWF might enhance the metastatic activity of pancreatic cancer and result in a poorer prognosis [38]. GNG11 participates in EMT and strongly regulates cellular senescence. The amplification of its gene leads to the activation of the Ras/Raf/MEK pathway in this tumor with wild-type RAS and RAF genes [39,40,41]. FGF7 and TNXB (tenascin X plays a role in organizing and maintaining the structure of muscle tissues, connective tissues, etc., by producing and assembling certain types of collagen) can increase pancreatic cancer cell migration and invasion [42,43,44]. The expression of TNXB is downregulated in some pancreatic cell lines [45], and it is correlated with a good survival prognosis in pan-cancer [46]. IL3RA (CD123) encodes a subunit of a receptor for IL-3. It plays a dual role in the immune system and promotes vessel formation [47]. High levels of IL3RA were found in pancreatic ductal adenocarcinoma patients with improved survival [48]. Lysophosphatidic acid receptor 1 (LPAR1) not only regulates the development of intratumoral heterogeneity [49] but also is crucial for chemotaxis and dissemination of pancreatic cancer cells [50]. TNXB and LPAR1 are also associated with activated PI3K/AKT [43,49]. The above-mentioned findings suggest that the final survival results are influenced by many factors, such as motility, heterogeneity, and the surrounding environment (including immune cells and blood vessels) of cancer cells rather than the expression of DEGs in cancer cells. Along with the results of these above-mentioned studies, our findings might provide new insights into the pathogenesis of pancreatic cancer and its treatment.

Our study had some limitations. First, non-homogeneous distribution of blood vessels occurs widely in tumors, and stereoscopy analysis based on serial sections is necessary to evaluate angiogenesis. However, we did not have the sample tissues sectioned serially, and thus, we could only make descriptive and qualitative statements about the representative H&E stained images. Also, the six related genes, such as VMW, might be important for evaluating the effects of PROK-1 knockdown in pancreatic cancer cells, and further experiments were required to elucidate their role. However, due to limited time and budget, they were neglected. We aim to investigate these molecules in follow-up studies.

5 Conclusion

To summarize, we found that PROK1 knockdown promoted cell apoptosis, which was characterized by an increase in TUNEL-positive staining, Bax protein levels, and caspase-3 cleavage. PROK1 knockdown also inhibited the proliferation of pancreatic cancer cells, characterized by a decrease in PCNA and cyclin D1 levels, leading to slow growth of PC in vivo. Furthermore, a decrease in the PROK1 levels inactivated the PI3K/AKT/mTOR pathway along with the associated molecules, which probably involves VWF, GNG11, FGF7, TNXB, IL3RA, and LPAR1. Therefore, PROK1 might be a potential molecular target for pancreatic cancer therapy, and further studies on it, along with its related genes, might be valuable for treating pancreatic cancer.


# Contributed equally, they are co-first authors.

tel: +86-0951-6744457, fax: +86-0951-6744457

Acknowledgments

We thank ExEditing.com for providing excellent language editing and polishing for this paper.

  1. Funding information: This study was financially supported by school-level project of Ningxia Medical University in 2014 (Grant No. XZ201418), Ningxia Natural Science Foundation in 2015 (Grant No. NZ15281), Innovation and Entrepreneurship Individual Project of Overseas Students in the Ningxia Hui Autonomous Region in 2015, Scientific Research Project of Ningxia Medical University in 2015 (Grant No. 2001060304), and Scientific Research Project of Ningxia Medical University in 2017 (Grant No. XY201720).

  2. Author contributions: F.W. and X.G.Y. performed the experiments and collected the data, and they were major contributors in writing the manuscript and were considered as co-first authors. Y.Q.H., J.J.S., D.L., and C.Y. were responsible for data analysis and visualization. F.P. and F.P.K. were responsible for literature search and data interpretation. Y.F.H. contributed to study concept and design, and was a major contributor in critically revising the manuscript. All authors read and approved the final manuscript.

  3. Conflict of interest: Authors state no conflict of interest.

  4. Data availability statement: The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

References

[1] Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.10.3322/caac.21660Search in Google Scholar PubMed

[2] Wu LM, Zhang LL, Chen XH, Zheng SS. Is irreversible electroporation safe and effective in the treatment of hepatobiliary and pancreatic cancers? Hepatobiliary Pancreat Dis Int. 2019;18(2):117–24.10.1016/j.hbpd.2019.01.001Search in Google Scholar PubMed

[3] Rhee H, Park MS. The role of imaging in current treatment strategies for pancreatic adenocarcinoma. Korean J Radiol. 2021;22(1):23–40.10.3348/kjr.2019.0862Search in Google Scholar PubMed PubMed Central

[4] Wang D, Rodriguez EA, Barkin JS, Donath EM, Pakravan AS. Statin use shows increased overall survival in patients diagnosed with pancreatic cancer: A meta-analysis. Pancreas. 2019;48(4):e22–3.10.1097/MPA.0000000000001276Search in Google Scholar PubMed

[5] Melincovici CS, Bosca AB, Susman S, Marginean M, Mihu C, Istrate M, et al. Vascular endothelial growth factor (VEGF)-key factor in normal and pathological angiogenesis. Rom J Morphol Embryol. 2018;59(2):455–67.Search in Google Scholar

[6] Corlan AS, Cîmpean AM, Jitariu AA, Melnic E, Raica M. Endocrine gland-derived vascular endothelial growth Factor/Prokineticin-1 in cancer development and tumor angiogenesis. Int J Endocrinol. 2017;2017:3232905.10.1155/2017/3232905Search in Google Scholar PubMed PubMed Central

[7] Jiang X, Abiatari I, Kong B, Erkan M, De Oliveira T, Giese NA, et al. Pancreatic islet and stellate cells are the main sources of endocrine gland-derived vascular endothelial growth factor/prokineticin-1 in pancreatic cancer. Pancreatology. 2009;9(1):165–72.10.1159/000178888Search in Google Scholar PubMed

[8] Yan X, Hui Y, Hua Y, Huang L, Wang L, Peng F, et al. EG-VEGF silencing inhibits cell proliferation and promotes cell apoptosis in pancreatic carcinoma via PI3K/AKT/mTOR signaling pathway. Biomed Pharmacother. 2019;109:762–9.10.1016/j.biopha.2018.10.125Search in Google Scholar PubMed

[9] Yu L, Wei J, Liu P. Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer. Semin Cancer Biol. 2022;85:69–94.10.1016/j.semcancer.2021.06.019Search in Google Scholar PubMed

[10] Lien EC, Dibble CC, Toker A. PI3K signaling in cancer: Beyond AKT. Curr Opin Cell Biol. 2017;45:62–71.10.1016/j.ceb.2017.02.007Search in Google Scholar PubMed PubMed Central

[11] Zhao L, Vogt PK. Class I PI3K in oncogenic cellular transformation. Oncogene. 2008;27(41):5486–96.10.1038/onc.2008.244Search in Google Scholar PubMed PubMed Central

[12] Zhu YP, Brown JR, Sag D, Zhang L, Suttles J. Adenosine 5′-monophosphate-activated protein kinase regulates IL-10-mediated anti-inflammatory signaling pathways in macrophages. J Immunol. 2015;194(2):584–94.10.4049/jimmunol.1401024Search in Google Scholar PubMed PubMed Central

[13] Jin S, Borkhuu O, Bao W, Yang YT. Signaling pathways in thyroid cancer and their therapeutic implications. J Clin Med Res. 2016;8(4):284–96.10.14740/jocmr2480wSearch in Google Scholar PubMed PubMed Central

[14] Zou Z, Tao T, Li H, Zhu X. mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges. Cell Biosci. 2020;10:31.10.1186/s13578-020-00396-1Search in Google Scholar PubMed PubMed Central

[15] Zhang Y, Cheng H, Li W, Wu H, Yang Y. Highly-expressed P2X7 receptor promotes growth and metastasis of human HOS/MNNG osteosarcoma cells via PI3K/Akt/GSK3β/β-catenin and mTOR/HIF1α/VEGF signaling. Int J Cancer. 2019;145(4):1068–82.10.1002/ijc.32207Search in Google Scholar PubMed PubMed Central

[16] LoPiccolo J, Blumenthal GM, Bernstein WB, Dennis PA. Targeting the PI3K/Akt/mTOR pathway: Effective combinations and clinical considerations. Drug Resist Updat. 2008;11(1–2):32–50.10.1016/j.drup.2007.11.003Search in Google Scholar PubMed PubMed Central

[17] Wolpin BM, Hezel AF, Abrams T, Blaszkowsky LS, Meyerhardt JA, Chan JA, et al. Oral mTOR inhibitor everolimus in patients with gemcitabine-refractory metastatic pancreatic cancer. J Clin Oncol. 2009;27(2):193–8.10.1200/JCO.2008.18.9514Search in Google Scholar PubMed PubMed Central

[18] Goryszewska-Szczurek E, Baryla M, Kaczynski P, Waclawik A. Prokineticin 1-prokineticin receptor 1 signaling in trophoblast promotes embryo implantation and placenta development. Sci Rep. 2021;11(1):13715.10.1038/s41598-021-93102-1Search in Google Scholar PubMed PubMed Central

[19] Goi T, Nakazawa T, Hirono Y, Yamaguchi A. The anti-tumor effect is enhanced by simultaneously targeting VEGF and PROK1 in colorectal cancer. Oncotarget. 2015;6(8):6053–61.10.18632/oncotarget.3474Search in Google Scholar PubMed PubMed Central

[20] Soundararajan R, Rao AJ. Trophoblast ‘pseudo-tumorigenesis’: significance and contributory factors. Reprod Biol Endocrinol. 2004;2:15.10.1186/1477-7827-2-15Search in Google Scholar PubMed PubMed Central

[21] Kisliouk T, Friedman A, Klipper E, Zhou QY, Schams D, Alfaidy N, et al. Expression pattern of prokineticin 1 and its receptors in bovine ovaries during the estrous cycle: involvement in corpus luteum regression and follicular atresia. Biol Reprod. 2007;76(5):749–58.10.1095/biolreprod.106.054734Search in Google Scholar PubMed

[22] Ngan ES, Sit FY, Lee K, Miao X, Yuan Z, Wang W, et al. Implications of endocrine gland-derived vascular endothelial growth factor/prokineticin-1 signaling in human neuroblastoma progression. Clin Cancer Res. 2007;13(3):868–75.10.1158/1078-0432.CCR-06-2176Search in Google Scholar PubMed

[23] Tagai N, Goi T, Shimada M, Kurebayashi H. Plasma Prokineticin 1, a prognostic biomarker in colorectal cancer patients with curative resection: a retrospective cohort study. World J Surg Oncol. 2021;19(1):302.10.1186/s12957-021-02421-0Search in Google Scholar PubMed PubMed Central

[24] Arora J, Sauer SJ, Tarpley M, Vermeulen P, Rypens C, Van Laere S, et al. Inflammatory breast cancer tumor emboli express high levels of anti-apoptotic proteins: Use of a quantitative high content and high-throughput 3D IBC spheroid assay to identify targeting strategies. Oncotarget. 2017;8(16):25848.10.18632/oncotarget.15667Search in Google Scholar PubMed PubMed Central

[25] Xu B, Lian S, Guo JR, Wang JF, Zhang LP, Li SZ, et al. Activation of the MAPK signaling pathway induces upregulation of pro-apoptotic proteins in the hippocampi of cold stressed adolescent mice. Neurosci Lett. 2019;699:97–102.10.1016/j.neulet.2018.12.028Search in Google Scholar PubMed

[26] Basu A, Haldar S. The relationship between BcI2, Bax and p53: consequences for cell cycle progression and cell death. Mol Hum Reprod. 1998;4(12):1099–109.10.1093/molehr/4.12.1099Search in Google Scholar PubMed

[27] Wang KS, Chan CK, Hidayat AFA, Wong YH, Kadir HA. Clinacanthus nutans induced reactive oxygen species-dependent apoptosis and autophagy in HCT116 human colorectal cancer cells. Pharmacogn Mag. 2019;15(60):87.10.4103/pm.pm_299_17Search in Google Scholar

[28] Porter AG, Jänicke RU. Emerging roles of caspase-3 in apoptosis. Cell Death Differ. 1999;6(2):99–104.10.1038/sj.cdd.4400476Search in Google Scholar PubMed

[29] Ponder KG, Boise LH. The prodomain of caspase-3 regulates its own removal and caspase activation. Cell Death Discov. 2019;5:56.10.1038/s41420-019-0142-1Search in Google Scholar PubMed PubMed Central

[30] Huang TC, Chiu PR, Chang WT, Hsieh BS, Huang YC, Cheng HL, et al. Epirubicin induces apoptosis in osteoblasts through death-receptor and mitochondrial pathways. Apoptosis. 2018;23(3–4):226–36.10.1007/s10495-018-1450-2Search in Google Scholar PubMed

[31] Shi JF, Lu BL, Huang B, Mao R, Tang JY, Zhu XY. Research progress of an novel vascular endothelial growth factor EG-VEGF/PROK1 in tumors. J Mod Oncol. 2018;22:3682–6.Search in Google Scholar

[32] Ren LN, Li QF, Xiao FJ, Yan J, Yang YF, Wang LS, et al. Endocrine glands-derived vascular endothelial growth factor protects pancreatic cancer cells from apoptosis via upregulation of the myeloid cell leukemia-1 protein. Biochem Biophys Res Commun. 2009;386(1):35–9.10.1016/j.bbrc.2009.05.149Search in Google Scholar PubMed

[33] Mi Y, Xiao C, Du Q, Wu W, Qi G, Liu X. Momordin Ic couples apoptosis with autophagy in human hepatoblastoma cancer cells by reactive oxygen species (ROS)-mediated PI3K/Akt and MAPK signaling pathways. Free Radic Biol Med. 2016;90:230–42.10.1016/j.freeradbiomed.2015.11.022Search in Google Scholar PubMed

[34] Granato M, Rizzello C, Gilardini Montani MS, Cuomo L, Vitillo M, Santarelli R, et al. Quercetin induces apoptosis and autophagy in primary effusion lymphoma cells by inhibiting PI3K/AKT/mTOR and STAT3 signaling pathways. J Nutr Biochem. 2017;41:124–36.10.1016/j.jnutbio.2016.12.011Search in Google Scholar PubMed

[35] Wang SS, Chen YH, Chen N, Wang LJ, Chen DX, Weng HL, et al. Hydrogen sulfide promotes autophagy of hepatocellular carcinoma cells through the PI3K/Akt/mTOR signaling pathway. Cell Death Dis. 2017;8(3):e2688.10.1038/cddis.2017.18Search in Google Scholar PubMed PubMed Central

[36] Saini S, Maker AV, Burman KD, Prabhakar BS. Molecular aberrations and signaling cascades implicated in the pathogenesis of anaplastic thyroid cancer. Biochim Biophys Acta Rev Cancer. 2019;1872(2):188262.10.1016/j.bbcan.2018.12.003Search in Google Scholar PubMed

[37] Markocka-Mączka K. Von Willebrand factor (vWF) in plasma of patients with pancreatic carcinoma. Contemp Oncol. 2002;6(5):322–6.Search in Google Scholar

[38] Patmore S, Dhami SPS, O’Sullivan JM. Von Willebrand factor and cancer; metastasis and coagulopathies. J Thromb Haemost. 2020;18(10):2444–56.10.1111/jth.14976Search in Google Scholar PubMed

[39] Kosr MA, Ju D. The CXCL7/CXCR2 axis and the migration of breast cells toward the malignant phenotype. J Clin Oncol. 2012;30(27_suppl):181.10.1200/jco.2012.30.27_suppl.181Search in Google Scholar

[40] Miwa T, Kanda M, Tanaka H, Tanaka C, Kobayashi D, Umeda S, et al. FBXO50 enhances the malignant behavior of gastric cancer cells. Ann Surg Oncol. 2017;24(12):3771–9.10.1245/s10434-017-5882-7Search in Google Scholar PubMed

[41] Hossain MN, Sakemura R, Fujii M, Ayusawa D. G-protein gamma subunit GNG11 strongly regulates cellular senescence. Biochem Biophys Res Commun. 2006;351(3):645–50.10.1016/j.bbrc.2006.10.112Search in Google Scholar PubMed

[42] Huang T, Wang L, Liu D, Li P, Xiong H, Zhuang L, et al. FGF7/FGFR2 signal promotes invasion and migration in human gastric cancer through upregulation of thrombospondin-1. Int J Oncol. 2017;50(5):1501–12.10.3892/ijo.2017.3927Search in Google Scholar PubMed PubMed Central

[43] Yan SP, Chu DX, Qiu HF, Xie Y, Wang CF, Zhang JY, et al. LncRNA LINC01305 silencing inhibits cell epithelial-mesenchymal transition in cervical cancer by inhibiting TNXB-mediated PI3K/Akt signalling pathway. J Cell Mol Med. 2019;23(4):2656–66.10.1111/jcmm.14161Search in Google Scholar PubMed PubMed Central

[44] Carter EP, Coetzee AS, Tomas Bort E, Wang Q, Kocher HM, Grose RP. Dissecting FGF signalling to target cellular crosstalk in pancreatic cancer. Cells. 2021;10(4):847.10.3390/cells10040847Search in Google Scholar PubMed PubMed Central

[45] Shimizu H, Horii A, Sunamura M, Motoi F, Egawa S, Unno M, et al. Identification of epigenetically silenced genes in human pancreatic cancer by a novel method “microarray coupled with methyl-CpG targeted transcriptional activation” (MeTA-array). Biochem Biophys Res Commun. 2011;411(1):162–7.10.1016/j.bbrc.2011.06.121Search in Google Scholar PubMed

[46] Liot S, Aubert A, Hervieu V, Kholti NE, Schalkwijk J, Verrier B, et al. Loss of Tenascin-X expression during tumor progression: A new pan-cancer marker. Matrix Biol Plus. 2020;6–7:100021.10.1016/j.mbplus.2020.100021Search in Google Scholar PubMed PubMed Central

[47] Lombardo G, Gili M, Grange C, Cavallari C, Dentelli P, Togliatto G, et al. IL-3R-alpha blockade inhibits tumor endothelial cell-derived extracellular vesicle (EV)-mediated vessel formation by targeting the β-catenin pathway. Oncogene. 2018;37(9):1175–91.10.1038/s41388-017-0034-xSearch in Google Scholar PubMed PubMed Central

[48] Boucher Y, Posada JM, Subudhi S, Rosario SR, Gu L, Kumar AS, et al. Addition of losartan to FOLFORINOX and chemoradiation downregulates pro-invasion and immunosuppression-associated genes in locally advanced pancreatic cancer. medRxiv. 2022.06.09.22275912. 2022. 10.1101/2022.06.09.22275912.Search in Google Scholar

[49] Cui R, Cao G, Bai H, Zhang Z. LPAR1 regulates the development of intratumoral heterogeneity in ovarian serous cystadenocarcinoma by activating the PI3K/AKT signaling pathway. Cancer Cell Int. 2019;19(1):201.10.1186/s12935-019-0920-0Search in Google Scholar PubMed PubMed Central

[50] Juin A, Spence HJ, Martin KJ, McGhee E, Neilson M, Cutiongco MFA, et al. N-WASP control of LPAR1 trafficking establishes response to self-generated LPA gradients to promote pancreatic cancer cell metastasis. Dev Cell. 2019;51(4):431–45.e7.10.1016/j.devcel.2019.09.018Search in Google Scholar PubMed PubMed Central

Received: 2022-04-21
Revised: 2022-09-28
Accepted: 2022-11-21
Published Online: 2023-04-10

© 2023 the author(s), published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Biomedical Sciences
  2. Systemic investigation of inetetamab in combination with small molecules to treat HER2-overexpressing breast and gastric cancers
  3. Immunosuppressive treatment for idiopathic membranous nephropathy: An updated network meta-analysis
  4. Identifying two pathogenic variants in a patient with pigmented paravenous retinochoroidal atrophy
  5. Effects of phytoestrogens combined with cold stress on sperm parameters and testicular proteomics in rats
  6. A case of pulmonary embolism with bad warfarin anticoagulant effects caused by E. coli infection
  7. Neutrophilia with subclinical Cushing’s disease: A case report and literature review
  8. Isoimperatorin alleviates lipopolysaccharide-induced periodontitis by downregulating ERK1/2 and NF-κB pathways
  9. Immunoregulation of synovial macrophages for the treatment of osteoarthritis
  10. Novel CPLANE1 c.8948dupT (p.P2984Tfs*7) variant in a child patient with Joubert syndrome
  11. Antiphospholipid antibodies and the risk of thrombosis in myeloproliferative neoplasms
  12. Immunological responses of septic rats to combination therapy with thymosin α1 and vitamin C
  13. High glucose and high lipid induced mitochondrial dysfunction in JEG-3 cells through oxidative stress
  14. Pharmacological inhibition of the ubiquitin-specific protease 8 effectively suppresses glioblastoma cell growth
  15. Levocarnitine regulates the growth of angiotensin II-induced myocardial fibrosis cells via TIMP-1
  16. Age-related changes in peripheral T-cell subpopulations in elderly individuals: An observational study
  17. Single-cell transcription analysis reveals the tumor origin and heterogeneity of human bilateral renal clear cell carcinoma
  18. Identification of iron metabolism-related genes as diagnostic signatures in sepsis by blood transcriptomic analysis
  19. Long noncoding RNA ACART knockdown decreases 3T3-L1 preadipocyte proliferation and differentiation
  20. Surgery, adjuvant immunotherapy plus chemotherapy and radiotherapy for primary malignant melanoma of the parotid gland (PGMM): A case report
  21. Dosimetry comparison with helical tomotherapy, volumetric modulated arc therapy, and intensity-modulated radiotherapy for grade II gliomas: A single‑institution case series
  22. Soy isoflavone reduces LPS-induced acute lung injury via increasing aquaporin 1 and aquaporin 5 in rats
  23. Refractory hypokalemia with sexual dysplasia and infertility caused by 17α-hydroxylase deficiency and triple X syndrome: A case report
  24. Meta-analysis of cancer risk among end stage renal disease undergoing maintenance dialysis
  25. 6-Phosphogluconate dehydrogenase inhibition arrests growth and induces apoptosis in gastric cancer via AMPK activation and oxidative stress
  26. Experimental study on the optimization of ANM33 release in foam cells
  27. Primary retroperitoneal angiosarcoma: A case report
  28. Metabolomic analysis-identified 2-hydroxybutyric acid might be a key metabolite of severe preeclampsia
  29. Malignant pleural effusion diagnosis and therapy
  30. Effect of spaceflight on the phenotype and proteome of Escherichia coli
  31. Comparison of immunotherapy combined with stereotactic radiotherapy and targeted therapy for patients with brain metastases: A systemic review and meta-analysis
  32. Activation of hypermethylated P2RY1 mitigates gastric cancer by promoting apoptosis and inhibiting proliferation
  33. Association between the VEGFR-2 -604T/C polymorphism (rs2071559) and type 2 diabetic retinopathy
  34. The role of IL-31 and IL-34 in the diagnosis and treatment of chronic periodontitis
  35. Triple-negative mouse breast cancer initiating cells show high expression of beta1 integrin and increased malignant features
  36. mNGS facilitates the accurate diagnosis and antibiotic treatment of suspicious critical CNS infection in real practice: A retrospective study
  37. The apatinib and pemetrexed combination has antitumor and antiangiogenic effects against NSCLC
  38. Radiotherapy for primary thyroid adenoid cystic carcinoma
  39. Design and functional preliminary investigation of recombinant antigen EgG1Y162–EgG1Y162 against Echinococcus granulosus
  40. Effects of losartan in patients with NAFLD: A meta-analysis of randomized controlled trial
  41. Bibliometric analysis of METTL3: Current perspectives, highlights, and trending topics
  42. Performance comparison of three scaling algorithms in NMR-based metabolomics analysis
  43. PI3K/AKT/mTOR pathway and its related molecules participate in PROK1 silence-induced anti-tumor effects on pancreatic cancer
  44. The altered expression of cytoskeletal and synaptic remodeling proteins during epilepsy
  45. Effects of pegylated recombinant human granulocyte colony-stimulating factor on lymphocytes and white blood cells of patients with malignant tumor
  46. Prostatitis as initial manifestation of Chlamydia psittaci pneumonia diagnosed by metagenome next-generation sequencing: A case report
  47. NUDT21 relieves sevoflurane-induced neurological damage in rats by down-regulating LIMK2
  48. Association of interleukin-10 rs1800896, rs1800872, and interleukin-6 rs1800795 polymorphisms with squamous cell carcinoma risk: A meta-analysis
  49. Exosomal HBV-DNA for diagnosis and treatment monitoring of chronic hepatitis B
  50. Shear stress leads to the dysfunction of endothelial cells through the Cav-1-mediated KLF2/eNOS/ERK signaling pathway under physiological conditions
  51. Interaction between the PI3K/AKT pathway and mitochondrial autophagy in macrophages and the leukocyte count in rats with LPS-induced pulmonary infection
  52. Meta-analysis of the rs231775 locus polymorphism in the CTLA-4 gene and the susceptibility to Graves’ disease in children
  53. Cloning, subcellular localization and expression of phosphate transporter gene HvPT6 of hulless barley
  54. Coptisine mitigates diabetic nephropathy via repressing the NRLP3 inflammasome
  55. Significant elevated CXCL14 and decreased IL-39 levels in patients with tuberculosis
  56. Whole-exome sequencing applications in prenatal diagnosis of fetal bowel dilatation
  57. Gemella morbillorum infective endocarditis: A case report and literature review
  58. An unusual ectopic thymoma clonal evolution analysis: A case report
  59. Severe cumulative skin toxicity during toripalimab combined with vemurafenib following toripalimab alone
  60. Detection of V. vulnificus septic shock with ARDS using mNGS
  61. Novel rare genetic variants of familial and sporadic pulmonary atresia identified by whole-exome sequencing
  62. The influence and mechanistic action of sperm DNA fragmentation index on the outcomes of assisted reproduction technology
  63. Novel compound heterozygous mutations in TELO2 in an infant with You-Hoover-Fong syndrome: A case report and literature review
  64. ctDNA as a prognostic biomarker in resectable CLM: Systematic review and meta-analysis
  65. Diagnosis of primary amoebic meningoencephalitis by metagenomic next-generation sequencing: A case report
  66. Phylogenetic analysis of promoter regions of human Dolichol kinase (DOLK) and orthologous genes using bioinformatics tools
  67. Collagen changes in rabbit conjunctiva after conjunctival crosslinking
  68. Effects of NM23 transfection of human gastric carcinoma cells in mice
  69. Oral nifedipine and phytosterol, intravenous nicardipine, and oral nifedipine only: Three-arm, retrospective, cohort study for management of severe preeclampsia
  70. Case report of hepatic retiform hemangioendothelioma: A rare tumor treated with ultrasound-guided microwave ablation
  71. Curcumin induces apoptosis in human hepatocellular carcinoma cells by decreasing the expression of STAT3/VEGF/HIF-1α signaling
  72. Rare presentation of double-clonal Waldenström macroglobulinemia with pulmonary embolism: A case report
  73. Giant duplication of the transverse colon in an adult: A case report and literature review
  74. Ectopic thyroid tissue in the breast: A case report
  75. SDR16C5 promotes proliferation and migration and inhibits apoptosis in pancreatic cancer
  76. Vaginal metastasis from breast cancer: A case report
  77. Screening of the best time window for MSC transplantation to treat acute myocardial infarction with SDF-1α antibody-loaded targeted ultrasonic microbubbles: An in vivo study in miniswine
  78. Inhibition of TAZ impairs the migration ability of melanoma cells
  79. Molecular complexity analysis of the diagnosis of Gitelman syndrome in China
  80. Effects of maternal calcium and protein intake on the development and bone metabolism of offspring mice
  81. Identification of winter wheat pests and diseases based on improved convolutional neural network
  82. Ultra-multiplex PCR technique to guide treatment of Aspergillus-infected aortic valve prostheses
  83. Virtual high-throughput screening: Potential inhibitors targeting aminopeptidase N (CD13) and PIKfyve for SARS-CoV-2
  84. Immune checkpoint inhibitors in cancer patients with COVID-19
  85. Utility of methylene blue mixed with autologous blood in preoperative localization of pulmonary nodules and masses
  86. Integrated analysis of the microbiome and transcriptome in stomach adenocarcinoma
  87. Berberine suppressed sarcopenia insulin resistance through SIRT1-mediated mitophagy
  88. DUSP2 inhibits the progression of lupus nephritis in mice by regulating the STAT3 pathway
  89. Lung abscess by Fusobacterium nucleatum and Streptococcus spp. co-infection by mNGS: A case series
  90. Genetic alterations of KRAS and TP53 in intrahepatic cholangiocarcinoma associated with poor prognosis
  91. Granulomatous polyangiitis involving the fourth ventricle: Report of a rare case and a literature review
  92. Studying infant mortality: A demographic analysis based on data mining models
  93. Metaplastic breast carcinoma with osseous differentiation: A report of a rare case and literature review
  94. Protein Z modulates the metastasis of lung adenocarcinoma cells
  95. Inhibition of pyroptosis and apoptosis by capsaicin protects against LPS-induced acute kidney injury through TRPV1/UCP2 axis in vitro
  96. TAK-242, a toll-like receptor 4 antagonist, against brain injury by alleviates autophagy and inflammation in rats
  97. Primary mediastinum Ewing’s sarcoma with pleural effusion: A case report and literature review
  98. Association of ADRB2 gene polymorphisms and intestinal microbiota in Chinese Han adolescents
  99. Tanshinone IIA alleviates chondrocyte apoptosis and extracellular matrix degeneration by inhibiting ferroptosis
  100. Study on the cytokines related to SARS-Cov-2 in testicular cells and the interaction network between cells based on scRNA-seq data
  101. Effect of periostin on bone metabolic and autophagy factors during tooth eruption in mice
  102. HP1 induces ferroptosis of renal tubular epithelial cells through NRF2 pathway in diabetic nephropathy
  103. Intravaginal estrogen management in postmenopausal patients with vaginal squamous intraepithelial lesions along with CO2 laser ablation: A retrospective study
  104. Hepatocellular carcinoma cell differentiation trajectory predicts immunotherapy, potential therapeutic drugs, and prognosis of patients
  105. Effects of physical exercise on biomarkers of oxidative stress in healthy subjects: A meta-analysis of randomized controlled trials
  106. Identification of lysosome-related genes in connection with prognosis and immune cell infiltration for drug candidates in head and neck cancer
  107. Development of an instrument-free and low-cost ELISA dot-blot test to detect antibodies against SARS-CoV-2
  108. Research progress on gas signal molecular therapy for Parkinson’s disease
  109. Adiponectin inhibits TGF-β1-induced skin fibroblast proliferation and phenotype transformation via the p38 MAPK signaling pathway
  110. The G protein-coupled receptor-related gene signatures for predicting prognosis and immunotherapy response in bladder urothelial carcinoma
  111. α-Fetoprotein contributes to the malignant biological properties of AFP-producing gastric cancer
  112. CXCL12/CXCR4/CXCR7 axis in placenta tissues of patients with placenta previa
  113. Association between thyroid stimulating hormone levels and papillary thyroid cancer risk: A meta-analysis
  114. Significance of sTREM-1 and sST2 combined diagnosis for sepsis detection and prognosis prediction
  115. Diagnostic value of serum neuroactive substances in the acute exacerbation of chronic obstructive pulmonary disease complicated with depression
  116. Research progress of AMP-activated protein kinase and cardiac aging
  117. TRIM29 knockdown prevented the colon cancer progression through decreasing the ubiquitination levels of KRT5
  118. Cross-talk between gut microbiota and liver steatosis: Complications and therapeutic target
  119. Metastasis from small cell lung cancer to ovary: A case report
  120. The early diagnosis and pathogenic mechanisms of sepsis-related acute kidney injury
  121. The effect of NK cell therapy on sepsis secondary to lung cancer: A case report
  122. Erianin alleviates collagen-induced arthritis in mice by inhibiting Th17 cell differentiation
  123. Loss of ACOX1 in clear cell renal cell carcinoma and its correlation with clinical features
  124. Signalling pathways in the osteogenic differentiation of periodontal ligament stem cells
  125. Crosstalk between lactic acid and immune regulation and its value in the diagnosis and treatment of liver failure
  126. Clinicopathological features and differential diagnosis of gastric pleomorphic giant cell carcinoma
  127. Traumatic brain injury and rTMS-ERPs: Case report and literature review
  128. Extracellular fibrin promotes non-small cell lung cancer progression through integrin β1/PTEN/AKT signaling
  129. Knockdown of DLK4 inhibits non-small cell lung cancer tumor growth by downregulating CKS2
  130. The co-expression pattern of VEGFR-2 with indicators related to proliferation, apoptosis, and differentiation of anagen hair follicles
  131. Inflammation-related signaling pathways in tendinopathy
  132. CD4+ T cell count in HIV/TB co-infection and co-occurrence with HL: Case report and literature review
  133. Clinical analysis of severe Chlamydia psittaci pneumonia: Case series study
  134. Bioinformatics analysis to identify potential biomarkers for the pulmonary artery hypertension associated with the basement membrane
  135. Influence of MTHFR polymorphism, alone or in combination with smoking and alcohol consumption, on cancer susceptibility
  136. Catharanthus roseus (L.) G. Don counteracts the ampicillin resistance in multiple antibiotic-resistant Staphylococcus aureus by downregulation of PBP2a synthesis
  137. Combination of a bronchogenic cyst in the thoracic spinal canal with chronic myelocytic leukemia
  138. Bacterial lipoprotein plays an important role in the macrophage autophagy and apoptosis induced by Salmonella typhimurium and Staphylococcus aureus
  139. TCL1A+ B cells predict prognosis in triple-negative breast cancer through integrative analysis of single-cell and bulk transcriptomic data
  140. Ezrin promotes esophageal squamous cell carcinoma progression via the Hippo signaling pathway
  141. Ferroptosis: A potential target of macrophages in plaque vulnerability
  142. Predicting pediatric Crohn's disease based on six mRNA-constructed risk signature using comprehensive bioinformatic approaches
  143. Applications of genetic code expansion and photosensitive UAAs in studying membrane proteins
  144. HK2 contributes to the proliferation, migration, and invasion of diffuse large B-cell lymphoma cells by enhancing the ERK1/2 signaling pathway
  145. IL-17 in osteoarthritis: A narrative review
  146. Circadian cycle and neuroinflammation
  147. Probiotic management and inflammatory factors as a novel treatment in cirrhosis: A systematic review and meta-analysis
  148. Hemorrhagic meningioma with pulmonary metastasis: Case report and literature review
  149. SPOP regulates the expression profiles and alternative splicing events in human hepatocytes
  150. Knockdown of SETD5 inhibited glycolysis and tumor growth in gastric cancer cells by down-regulating Akt signaling pathway
  151. PTX3 promotes IVIG resistance-induced endothelial injury in Kawasaki disease by regulating the NF-κB pathway
  152. Pancreatic ectopic thyroid tissue: A case report and analysis of literature
  153. The prognostic impact of body mass index on female breast cancer patients in underdeveloped regions of northern China differs by menopause status and tumor molecular subtype
  154. Report on a case of liver-originating malignant melanoma of unknown primary
  155. Case report: Herbal treatment of neutropenic enterocolitis after chemotherapy for breast cancer
  156. The fibroblast growth factor–Klotho axis at molecular level
  157. Characterization of amiodarone action on currents in hERG-T618 gain-of-function mutations
  158. A case report of diagnosis and dynamic monitoring of Listeria monocytogenes meningitis with NGS
  159. Effect of autologous platelet-rich plasma on new bone formation and viability of a Marburg bone graft
  160. Small breast epithelial mucin as a useful prognostic marker for breast cancer patients
  161. Continuous non-adherent culture promotes transdifferentiation of human adipose-derived stem cells into retinal lineage
  162. Nrf3 alleviates oxidative stress and promotes the survival of colon cancer cells by activating AKT/BCL-2 signal pathway
  163. Favorable response to surufatinib in a patient with necrolytic migratory erythema: A case report
  164. Case report of atypical undernutrition of hypoproteinemia type
  165. Down-regulation of COL1A1 inhibits tumor-associated fibroblast activation and mediates matrix remodeling in the tumor microenvironment of breast cancer
  166. Sarcoma protein kinase inhibition alleviates liver fibrosis by promoting hepatic stellate cells ferroptosis
  167. Research progress of serum eosinophil in chronic obstructive pulmonary disease and asthma
  168. Clinicopathological characteristics of co-existing or mixed colorectal cancer and neuroendocrine tumor: Report of five cases
  169. Role of menopausal hormone therapy in the prevention of postmenopausal osteoporosis
  170. Precisional detection of lymph node metastasis using tFCM in colorectal cancer
  171. Advances in diagnosis and treatment of perimenopausal syndrome
  172. A study of forensic genetics: ITO index distribution and kinship judgment between two individuals
  173. Acute lupus pneumonitis resembling miliary tuberculosis: A case-based review
  174. Plasma levels of CD36 and glutathione as biomarkers for ruptured intracranial aneurysm
  175. Fractalkine modulates pulmonary angiogenesis and tube formation by modulating CX3CR1 and growth factors in PVECs
  176. Novel risk prediction models for deep vein thrombosis after thoracotomy and thoracoscopic lung cancer resections, involving coagulation and immune function
  177. Exploring the diagnostic markers of essential tremor: A study based on machine learning algorithms
  178. Evaluation of effects of small-incision approach treatment on proximal tibia fracture by deep learning algorithm-based magnetic resonance imaging
  179. An online diagnosis method for cancer lesions based on intelligent imaging analysis
  180. Medical imaging in rheumatoid arthritis: A review on deep learning approach
  181. Predictive analytics in smart healthcare for child mortality prediction using a machine learning approach
  182. Utility of neutrophil–lymphocyte ratio and platelet–lymphocyte ratio in predicting acute-on-chronic liver failure survival
  183. A biomedical decision support system for meta-analysis of bilateral upper-limb training in stroke patients with hemiplegia
  184. TNF-α and IL-8 levels are positively correlated with hypobaric hypoxic pulmonary hypertension and pulmonary vascular remodeling in rats
  185. Stochastic gradient descent optimisation for convolutional neural network for medical image segmentation
  186. Comparison of the prognostic value of four different critical illness scores in patients with sepsis-induced coagulopathy
  187. Application and teaching of computer molecular simulation embedded technology and artificial intelligence in drug research and development
  188. Hepatobiliary surgery based on intelligent image segmentation technology
  189. Value of brain injury-related indicators based on neural network in the diagnosis of neonatal hypoxic-ischemic encephalopathy
  190. Analysis of early diagnosis methods for asymmetric dementia in brain MR images based on genetic medical technology
  191. Early diagnosis for the onset of peri-implantitis based on artificial neural network
  192. Clinical significance of the detection of serum IgG4 and IgG4/IgG ratio in patients with thyroid-associated ophthalmopathy
  193. Forecast of pain degree of lumbar disc herniation based on back propagation neural network
  194. SPA-UNet: A liver tumor segmentation network based on fused multi-scale features
  195. Systematic evaluation of clinical efficacy of CYP1B1 gene polymorphism in EGFR mutant non-small cell lung cancer observed by medical image
  196. Rehabilitation effect of intelligent rehabilitation training system on hemiplegic limb spasms after stroke
  197. A novel approach for minimising anti-aliasing effects in EEG data acquisition
  198. ErbB4 promotes M2 activation of macrophages in idiopathic pulmonary fibrosis
  199. Clinical role of CYP1B1 gene polymorphism in prediction of postoperative chemotherapy efficacy in NSCLC based on individualized health model
  200. Lung nodule segmentation via semi-residual multi-resolution neural networks
  201. Evaluation of brain nerve function in ICU patients with Delirium by deep learning algorithm-based resting state MRI
  202. A data mining technique for detecting malignant mesothelioma cancer using multiple regression analysis
  203. Markov model combined with MR diffusion tensor imaging for predicting the onset of Alzheimer’s disease
  204. Effectiveness of the treatment of depression associated with cancer and neuroimaging changes in depression-related brain regions in patients treated with the mediator-deuterium acupuncture method
  205. Molecular mechanism of colorectal cancer and screening of molecular markers based on bioinformatics analysis
  206. Monitoring and evaluation of anesthesia depth status data based on neuroscience
  207. Exploring the conformational dynamics and thermodynamics of EGFR S768I and G719X + S768I mutations in non-small cell lung cancer: An in silico approaches
  208. Optimised feature selection-driven convolutional neural network using gray level co-occurrence matrix for detection of cervical cancer
  209. Incidence of different pressure patterns of spinal cerebellar ataxia and analysis of imaging and genetic diagnosis
  210. Pathogenic bacteria and treatment resistance in older cardiovascular disease patients with lung infection and risk prediction model
  211. Adoption value of support vector machine algorithm-based computed tomography imaging in the diagnosis of secondary pulmonary fungal infections in patients with malignant hematological disorders
  212. From slides to insights: Harnessing deep learning for prognostic survival prediction in human colorectal cancer histology
  213. Ecology and Environmental Science
  214. Monitoring of hourly carbon dioxide concentration under different land use types in arid ecosystem
  215. Comparing the differences of prokaryotic microbial community between pit walls and bottom from Chinese liquor revealed by 16S rRNA gene sequencing
  216. Effects of cadmium stress on fruits germination and growth of two herbage species
  217. Bamboo charcoal affects soil properties and bacterial community in tea plantations
  218. Optimization of biogas potential using kinetic models, response surface methodology, and instrumental evidence for biodegradation of tannery fleshings during anaerobic digestion
  219. Understory vegetation diversity patterns of Platycladus orientalis and Pinus elliottii communities in Central and Southern China
  220. Studies on macrofungi diversity and discovery of new species of Abortiporus from Baotianman World Biosphere Reserve
  221. Food Science
  222. Effect of berrycactus fruit (Myrtillocactus geometrizans) on glutamate, glutamine, and GABA levels in the frontal cortex of rats fed with a high-fat diet
  223. Guesstimate of thymoquinone diversity in Nigella sativa L. genotypes and elite varieties collected from Indian states using HPTLC technique
  224. Analysis of bacterial community structure of Fuzhuan tea with different processing techniques
  225. Untargeted metabolomics reveals sour jujube kernel benefiting the nutritional value and flavor of Morchella esculenta
  226. Mycobiota in Slovak wine grapes: A case study from the small Carpathians wine region
  227. Elemental analysis of Fadogia ancylantha leaves used as a nutraceutical in Mashonaland West Province, Zimbabwe
  228. Microbiological transglutaminase: Biotechnological application in the food industry
  229. Influence of solvent-free extraction of fish oil from catfish (Clarias magur) heads using a Taguchi orthogonal array design: A qualitative and quantitative approach
  230. Chromatographic analysis of the chemical composition and anticancer activities of Curcuma longa extract cultivated in Palestine
  231. The potential for the use of leghemoglobin and plant ferritin as sources of iron
  232. Investigating the association between dietary patterns and glycemic control among children and adolescents with T1DM
  233. Bioengineering and Biotechnology
  234. Biocompatibility and osteointegration capability of β-TCP manufactured by stereolithography 3D printing: In vitro study
  235. Clinical characteristics and the prognosis of diabetic foot in Tibet: A single center, retrospective study
  236. Agriculture
  237. Biofertilizer and NPSB fertilizer application effects on nodulation and productivity of common bean (Phaseolus vulgaris L.) at Sodo Zuria, Southern Ethiopia
  238. On correlation between canopy vegetation and growth indexes of maize varieties with different nitrogen efficiencies
  239. Exopolysaccharides from Pseudomonas tolaasii inhibit the growth of Pleurotus ostreatus mycelia
  240. A transcriptomic evaluation of the mechanism of programmed cell death of the replaceable bud in Chinese chestnut
  241. Melatonin enhances salt tolerance in sorghum by modulating photosynthetic performance, osmoregulation, antioxidant defense, and ion homeostasis
  242. Effects of plant density on alfalfa (Medicago sativa L.) seed yield in western Heilongjiang areas
  243. Identification of rice leaf diseases and deficiency disorders using a novel DeepBatch technique
  244. Artificial intelligence and internet of things oriented sustainable precision farming: Towards modern agriculture
  245. Animal Sciences
  246. Effect of ketogenic diet on exercise tolerance and transcriptome of gastrocnemius in mice
  247. Combined analysis of mRNA–miRNA from testis tissue in Tibetan sheep with different FecB genotypes
  248. Isolation, identification, and drug resistance of a partially isolated bacterium from the gill of Siniperca chuatsi
  249. Tracking behavioral changes of confined sows from the first mating to the third parity
  250. The sequencing of the key genes and end products in the TLR4 signaling pathway from the kidney of Rana dybowskii exposed to Aeromonas hydrophila
  251. Development of a new candidate vaccine against piglet diarrhea caused by Escherichia coli
  252. Plant Sciences
  253. Crown and diameter structure of pure Pinus massoniana Lamb. forest in Hunan province, China
  254. Genetic evaluation and germplasm identification analysis on ITS2, trnL-F, and psbA-trnH of alfalfa varieties germplasm resources
  255. Tissue culture and rapid propagation technology for Gentiana rhodantha
  256. Effects of cadmium on the synthesis of active ingredients in Salvia miltiorrhiza
  257. Cloning and expression analysis of VrNAC13 gene in mung bean
  258. Chlorate-induced molecular floral transition revealed by transcriptomes
  259. Effects of warming and drought on growth and development of soybean in Hailun region
  260. Effects of different light conditions on transient expression and biomass in Nicotiana benthamiana leaves
  261. Comparative analysis of the rhizosphere microbiome and medicinally active ingredients of Atractylodes lancea from different geographical origins
  262. Distinguish Dianthus species or varieties based on chloroplast genomes
  263. Comparative transcriptomes reveal molecular mechanisms of apple blossoms of different tolerance genotypes to chilling injury
  264. Study on fresh processing key technology and quality influence of Cut Ophiopogonis Radix based on multi-index evaluation
  265. An advanced approach for fig leaf disease detection and classification: Leveraging image processing and enhanced support vector machine methodology
  266. Erratum
  267. Erratum to “Protein Z modulates the metastasis of lung adenocarcinoma cells”
  268. Erratum to “BRCA1 subcellular localization regulated by PI3K signaling pathway in triple-negative breast cancer MDA-MB-231 cells and hormone-sensitive T47D cells”
  269. Retraction
  270. Retraction to “Protocatechuic acid attenuates cerebral aneurysm formation and progression by inhibiting TNF-alpha/Nrf-2/NF-kB-mediated inflammatory mechanisms in experimental rats”
Downloaded on 27.1.2026 from https://www.degruyterbrill.com/document/doi/10.1515/biol-2022-0538/html
Scroll to top button